Prescription Drug Prices Continue to Surge
Initial prices for brand-name medications climbed steadily over two decades, with no immediate slowdown following the Inflation Reduction Act.1
Initial prices for brand-name medications climbed steadily over two decades, with no immediate slowdown following the Inflation Reduction Act.1
The federal agency restructured its flu and COVID-19 units into a unified Influenza and Respiratory Viruses Division (IRVD).
A study of California workers identified nearly 600 cases of the incurable lung condition silicosis, prompting experts to call for national surveillance and stronger safety standards.
Researchers identify blood markers that reveal early biological stress from pollution exposure before chronic illness develops.
The BreatheLink platform allows patients to transmit overnight oximetry data from their own smartphones, reducing the time required to set up home oxygen therapy.
A survey of frontline healthcare workers suggests a protein-based COVID-19 vaccine may cause fewer symptoms and less work disruption compared to mRNA options.
Remote telemedicine consultations can help clinicians avoid unnecessary patient transfers without increasing the risk of mortality.
Magnolia Diagnostics and its owners allegedly billed Medicare for unnecessary respiratory panels performed on seniors during the pandemic, according to the US Justice Dept.